ClinicalTrials.Veeva

Menu

Clinical Decision Support Algorithm to Predict Diabetic Retinopathy

O

Oklahoma State University Center for Health Sciences

Status

Unknown

Conditions

Diabetic Retinopathy

Treatments

Other: risk factors for diabetic retinopathy

Study type

Observational

Funder types

Other

Identifiers

NCT03769948
HR-18-087

Details and patient eligibility

About

Diabetic retinopathy (DR), a complication of diabetes, is a leading cause of blindness among working-aged adults globally. In its early stages, DR is symptomless, and can only be detected by an annual eye exam. Once the disease has progressed to the point where vision loss has occurred, the damage is irreversible. Consequently, early detection is quintessential in treating DR. Two barriers to early detection are poor patient compliance with the annual exam and lack of access to specialists in rural areas. This research is focused on developing and validating new, cost-effective predictive technologies that can improve early screening of DR. Our overall objective is to develop and implement an entire suite of tools to detect diabetes complications in order to augment care for underserved rural populations in the US and internationally.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

For diabetic patients with DR:

  • With 250.xx diabetes and 362.0x DR ICD-9 codes
  • All variables are complete within the observation window

For diabetic patients without DR:

  • With 250.xx diabetes ICD-9 codes
  • Without 362.0x DR ICD-9 codes
  • All variables are complete within the observation window

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems